Search results summary

From Health Canada

Search criteria

  • Status: Select all
  • AIG: 0108628003

Search results

List of returned drug products
Products returned by the search are listed, including their status, DIN number, name, class, total count of active ingredients and the name of one, etc. Clicking on the value in the DIN column returns more complete information about the related product.
Status DIN Company Product Class PM See footnote1 Schedule # See footnote2 A.I. name See footnote3 Strength
Cancelled Post Market 02350645 THE AVON COMPANY CANADA LIMITED ADVANCE TECHNIQUES KEEP CLEAR ANTI-DANDRUFF TREATMENT Human No OTC 1 PYRITHIONE ZINC 0.1 % / W/W
Cancelled Post Market 02302837 MATRIX CANADA BIOLAGE SCALPTHERAPIE ANTIDANDRUFF TREATMENT Human No OTC 1 PYRITHIONE ZINC 0.1 %
Cancelled Post Market 01908715 COMBE INCORPORATED BRYLCREEM ANTI-DANDRUFF Human No OTC 1 PYRITHIONE ZINC .1 %
Cancelled Post Market 02294966 REDKEN 5TH AVENUE NYC CHILL BLAST Human No OTC 1 PYRITHIONE ZINC 0.1 %
Cancelled Pre Market 02442477 PROCTER & GAMBLE INC CLINICAL SOLUTIONS DAILY SCALP TREATMENT Human No OTC 1 PYRITHIONE ZINC 0.1 % / W/W
Cancelled Pre Market 02446200 PROCTER & GAMBLE INC CLINICAL SOLUTIONS LEAVE-ON DANDRUFF TREATMENT Human No OTC 1 PYRITHIONE ZINC 0.1 % / W/W
Marketed 02502771 PROCTER & GAMBLE INC ITCH RELIEF SCALP MIST Human No OTC 1 PYRITHIONE ZINC 0.1 % / W/W
Cancelled Post Market 02248479 AFRICAN GOLD LIMITED NO MORE DANDRUFF HAIR AND SCALP CONDITIONER Human No OTC 1 PYRITHIONE ZINC 0.1 %
Cancelled Post Market 02308401 L OREAL PROFESSIONNEL CANADA POWER CLEAR Human No OTC 1 PYRITHIONE ZINC 0.1 %
Cancelled Post Market 02299917 REDKEN 5TH AVENUE NYC SCALP RELIEF DANDRUFF CONTROL LEAVE-IN TREATMENT Human No OTC 1 PYRITHIONE ZINC 0.1 %
Approved 02496593 PROCTER & GAMBLE INC SUPRÊME SOOTHING LEAVE ON SCALP CREAM Human No OTC 1 PYRITHIONE ZINC 0.1 % / W/W
Approved 02492512 PROCTER & GAMBLE INC SUPRÊME THICKENING HAIR MIST Human No OTC 1 PYRITHIONE ZINC 0.1 % / W/W
Version 4.0.3

"Page details"

Date modified: